Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene

Toxicology Letters

Volumn 211, Issue 3, 2012, Pages 266-273

  Kalabus, James L ^a   Cheng, Qiuying ^a   Jamil, Raqeeb G ^a   Schuetz, Erin G ^b   Blanco, Javier G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Benzo a pyrene; Cigarette smoke metabolism; Human carbonyl reductase 1 (CBR1)

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CARBONYL REDUCTASE 1; CIGARETTE SMOKE; MESSENGER RNA; NEURON SPECIFIC NUCLEAR PROTEIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL;

ALCOHOL OXIDOREDUCTASES; BENZO(A)PYRENE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CYTOSOL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENVIRONMENTAL POLLUTANTS; ENZYME INDUCTION; HUMANS; LUCIFERASES; LUNG; LUNG NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SMOKE; SMOKING; TOBACCO; TRANSFECTION;

EID: 84860504102     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.04.006     Document Type: Article

References (28)

1. Atalla A., Breyer-Pfaff U., Maser E. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol. Xenobiotica 2000, 30:755-769.
2. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annual Review of Pharmacology and Toxicology 2003, 43:309-334.
3. Dessypris E.N., Brenner D.E., Hande K.R. Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro. Cancer Treatment Reports 1986, 70:487-490.
4. Dorr R.T., Shipp N.G., Lee K.M. Comparison of cytotoxicity in heart cells and tumor cells exposed to DNA intercalating agents in vitro. Anticancer Drugs 1991, 2:27-33.
5. Dougherty E.J., Pollenz R.S. Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture. Toxicological Sciences 2008, 103:191-206.
6. Forrest G.L., Akman S., Krutzik S., Paxton R.J., Sparkes R.S., Doroshow J., Felsted R.L., Glover C.J., Mohandas T., Bachur N.R. Induction of a human carbonyl reductase gene located on chromosome 21. Biochimica et Biophysica Acta 1990, 1048:149-155.
7. Gonzalez-Covarrubias V., Zhang J., Kalabus J.L., Relling M.V., Blanco J.G. Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors. Drug Metabolism and Disposition: The Biological Fate of Chemicals 2009, 37:400-407.
8. Hankinson O. The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology 1995, 35:307-340.
9. Hecht S.S. Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute 1999, 91:1194-1210.
10. Hockley S.L., Arlt V.M., Brewer D., Te Poele R., Workman P., Giddings I., Phillips D.H. AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chemical Research in Toxicology 2007, 20:1797-1810.
11. Hoffmann F., Maser E. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metabolism Reviews 2007, 39:87-144.
12. Iizuka T., Ishii Y., Itoh K., Kiwamoto T., Kimura T., Matsuno Y., Morishima Y., Hegab A.E., Homma S., Nomura A., Sakamoto T., Shimura M., Yoshida A., Yamamoto M., Sekizawa K. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 2005, 10:1113-1125.
13. Kalabus J.L., Sanborn C.C., Jamil R.G., Cheng Q., Blanco J.G. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome. Drug Metabolism and Disposition: The Biological Fate of Chemicals 2010, 38:2096-2099.
14. Lakhman S.S., Chen X., Gonzalez-Covarrubias V., Schuetz E.G., Blanco J.G. Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor. Molecular Pharmacology 2007, 72:734-743.
15. Malatkova P., Maser E., Wsol V. Human carbonyl reductases. Current Drug Metabolism 2010, 11:639-658.
16. Maser E. Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends in Pharmacological Sciences 2004, 25:235-237.
17. Maser E., Stinner B., Atalla A. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung. Cancer Letters 2000, 148:135-144.
18. Matakidou A., Eisen T., Houlston R.S. Systematic review of the relationship between family history and lung cancer risk. British Journal of Cancer 2005, 93:825-833.
19. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacological Reviews 2004, 56:185-229.
20. Mordente A., Minotti G., Martorana G.E., Silvestrini A., Giardina B., Meucci E. Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications. Biochemical Pharmacology 2003, 66:989-998.
21. Schlager J.J., Powis G. Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. International Journal of Cancer 1990, 45:403-409.
22. Shen Y.M., Rattan V., Sultana C., Kalra V.K. Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. American Journal of Physiology 1996, 39:H1624-H1633.
23. Sobell H.M. Actinomycin and DNA transcription. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:5328-5331.
24. Vogel C.F., Sciullo E., Li W., Wong P., Lazennec G., Matsumura F. RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Molecular Endocrinology 2007, 21:2941-2955.
25. Wang X., Chorley B.N., Pittman G.S., Kleeberger S.R., Brothers J., Liu G., Spira A., Bell D.A. Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One 2010, 5:e11934.
26. Wermuth B. Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase. Journal of Biological Chemistry 1981, 256:1206-1213.
27. Wermuth B., Platts K.L., Seidel A., Oesch F. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man. Biochemical Pharmacology 1986, 35:1277-1282.
28. Wirth H., Wermuth B. Immunohistochemical localization of carbonyl reductase in human tissues. Journal of Histochemistry and Cytochemistry 1992, 40:1857-1863.